Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search Materials

A library of resources for the prevention,
management, and elimination of TB.

Showing 381 - 20 of 1147 Results

Number of items to view
Filter Your Results
Title Year

This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.

International Agencies Policy Makers
2016

This fact sheet provides information on latent tuberculosis infection (LTBI) for patients.

Persons With LTBI
2016

These guidelines aim to reduce morbidity and mortality related to TB and HIV-associated TB among people who inject drugs (PWID) through the integrated delivery of a comprehensive and holistic package of care. The guidelines provide an update of the 2008 Policy guidelines for collaborative TB and HIV services for injecting and other drug users: an integrated approach.

2016

This quick reference tool provides suggestions for replacing stigmatizing language with non-hurtful words and phrases.

2016

This guide provides an epidemiological profile of childhood TB, outlines the barriers to diagnosis and treatment, discusses strategies for improved access,and highlights opportunities for the involvement of children and their caregivers in all stages of program development and service delivery.

Policy Makers
2016

This report details the steps that governments of countries with high burdens of TB-HIV and their partners have taken to turn a coordinated response to TB-HIV into reality at the country level, as well as the remaining gaps.

International Agencies Policy Makers
2016

The purpose of this document is to provide guidance for clinicians, nurses, and hospital infection preventionists on the use of the Xpert MTB/RIF assay when making decisions to discontinue airborne infection isolation for persons with suspected, infectious pulmonary TB.

Infection Control and Occupational Health Workers
2016

This video provides information on how to administer directly observe therapy (DOT).

Outreach Workers
2016

This quick reference guide provides information on how to correctly administer and read a tuberculin skin test (TST).

2016

This website contains resources, materials, and links to latent TB infection and U.S. Preventive Services Task Force (USPSTF) materials.

2016

This slide set was developed as an accompaniment to Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection, a joint statement by CDC and the American Thoracic Society, and subsequent updates. The slide set provides an overview of the current recommendations for the testing and treatment of latent tuberculosis.

2016

This report provides surveillance data, concise summaries of core program activities, and highlights for 2015.

Health Educators/Communicators
2016

This guide aims to improve case detection, management, and outcomes of children with TB.

2016

The WHO treatment guidelines for drug-resistant TB contains policy recommendations on priority areas in the treatment of drug-resistant TB.

2016

This resource provides access to a variety of tools that enable health professionals to quickly and easily find information about TB in an emergency department setting.

2016

WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.

International Agencies Managers and Supervisors Policy Makers
2016

This brochure describes Mycobacterium bovis (bovine tuberculosis) in humans and in cattle.

2016

This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.

International Agencies
2016

This fact sheet provides an overview of treating TB disease in persons infected with HIV/AIDS.

2016

This report presents summary data for U.S. TB cases reported to the Division of TB Elimination, CDC, during 2015.

Policy Makers
2016